GlobeNewsWire
20 Nov 2026, 06:00 UTC · 1h ago
ADDEX THERAPEUTICS TO REPORT 2026 THIRD QUARTER FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 25, 2026
Impact · against what's priced in
Addex Therapeutics' announcement of its Q3 2026 results is a routine scheduling event. While it signals upcoming visibility into cash runway and pipeline timelines, the announcement itself contains no material data to shift current valuations.
Scored by the NIS engine · methodology.





